The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,801–18,900 of 31,469
The neuropeptide 26RFa in the human gut and pancreas: potential involvement in glucose homeostasis
Prévost, G., Picot, M., Solliec, M.-A. L., Arabo, A., Berrahmoune, H., Mehdi, M. E., Cherifi, S., Bénani, A., Nédélec, E., Gobet, F., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0247 · Cited by 13
Sönmez, H. E., Canpolat, N., Ağbaş, A., Taşdemir, M. S., Ekmekçi, Ö. B., Alikaşifoğlu, M., Sever, L., & Çalışkan, S. (2019) · Childhood Obesity · doi:10.1089/chi.2019.0022 · Cited by 13
Srinivasan, S., Jablonski, K. A., Knowler, W. C., Dagogo-Jack, S. E., Kahn, S. E., Boyko, E. J., Bray, G. A., Horton, E. S., Hivert, M., Goldberg, R. B., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00069 · Cited by 13
Carvalho, N., Júnior, F. A. O., da Silva, G., et al. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s204414 · Cited by 13
Tonomura, S., Naka, S., Tabata, K., Hara, T., Mori, K., Tanaka, S., Sumida, Y., Kanemasa, K., Nomura, R., Matsumoto‐Nakano, M., et al. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000329 · Cited by 14
Shi, W., Jiang, Y., Zhao, D., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110887 · Cited by 13
Semnani‐Azad, Z., Connelly, P. W., Johnston, L., Retnakaran, R. R., Harris, S. B., Zinman, B., & Hanley, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz166 · Cited by 13
Komada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., & Ogawa, W. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.002 · Cited by 15
Matsuo, A. R., Lopes, W. A., Locatelli, J. C., Simões, C. F., de Oliveira, G. H., & Nardo, N. (2020) · Nutrition · doi:10.1016/j.nut.2020.110744 · Cited by 13
Hernández, M. A. G., Canfora, E. E., Pasmans, K., Astrup, A. V., Saris, W. H. M., & Blaak, E. E. (2020) · Nutrients · doi:10.3390/nu12020339 · Cited by 14
Aspirin Mitigated Tumor Growth in Obese Mice Involving Metabolic Inhibition
Wang, J., Chen, W., Li, J., et al. (2020) · Cells · doi:10.3390/cells9030569 · Cited by 13
Wachal, Z., Bombicz, M., Priksz, D., Hegedűs, C., Kovács, D. K., Szabó, A. M., Kiss, R., Németh, J., Juhász, B., Szilvássy, Z., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062124 · Cited by 15
Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome
Alissa, E. M., Algarni, S. A., Khaffji, A. J., & Mansouri, N. M. A. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1697219 · Cited by 13
Abulmeaty, M. M. A., Aljuraiban, G. S., Alaidarous, T. A., & Alkahtani, N. M. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s248842 · Cited by 13
Barbot, M., Regazzo, D., Mondin, A., Zilio, M., Lizzul, L., Zaninotto, M., Plebani, M., Arnaldi, G., Ceccato, F., & Scaroni, C. M. (2020) · Pituitary · doi:10.1007/s11102-020-01055-x · Cited by 14
Evaluation of insulin resistance in overweight and obese dogs
R, R. S. J., & Víctor, C. (2020) · International Journal of Veterinary Science and Research · doi:10.17352/ijvsr.000055 · Cited by 13
Mustafa, S. A., & Younus, D. A. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00904-7 · Cited by 13
Han, S. J., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., & Boyko, E. J. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.351 · Cited by 13
ÇAKIT, M. O., Gümüştepe, A., Çakıt, B. D., Vural, S. P., Özgün, T., & Genç, H. (2020) · Archives of Rheumatology · doi:10.46497/archrheumatol.2021.7534 · Cited by 15
Lee, D., Chun, E. J., Moon, J. H., Yun, H. M., & Lim, S. K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14147 · Cited by 13
Awaad, A. K., Kamel, M. A. E.-N., Mohamed, M. M., Helmy, M. H., Youssef, M. I., Zaki, E. I., Essawy, M. M., & Hegazy, M. G. A. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00046-8 · Cited by 14
Association of age at menarche with hypertension in rural Chinese women
Liu, D., Qin, P., Liu, Y., Sun, X., Li, H., Wu, X., Zhang, Y., Han, M., Qie, R., Huang, S., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002672 · Cited by 13
B-vitamins and metabolic syndrome in Mesoamerican children and their adult parents
Santos, C. V., Ramírez‐Zea, M., Villamor, E., & for the Nine Mesoamerican Countries Metabolic Syndrome (NiMeCoMeS) Study Group (2020) · Public Health Nutrition · doi:10.1017/s1368980020003936 · Cited by 13
Lotan, R., Ganmore, I., Shelly, S., Zacharia, M., Uribarri, J., Beisswenger, P. J., Cai, W., Troen, A. M., & Beeri, M. S. (2020) · Nutrients · doi:10.3390/nu12103143 · Cited by 13
Romano, M., Piskin, D., Berard, R. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75433-7 · Cited by 13
LeCroy, M. N., Hua, S., Kaplan, R. C., Sotres‐Alvarez, D., Qi, Q., Thyagarajan, B., Gallo, L. C., Pirzada, A., Daviglus, M. L., Schneiderman, N., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108557 · Cited by 14
DeBoer, M. D., Lin, B., Filipp, S. L., Cusi, K. J., & Gurka, M. J. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.12.023 · Cited by 13
Labbaci, F. Z., & Boukortt, F. (2020) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2020.25.4.353 · Cited by 13
Insulin Resistance as a Diagnostic Criterion for Metabolically Healthy Obesity in Children
Nso‐Roca, A. P., Cortés-Castell, E., Carratalá-Marco, F., & Sánchez-Ferrer, F. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003097 · Cited by 13
Goletzke, J., Haene, J. D., Stotland, N. E., Murphy, E. J., Pérez‐Rodríguez, M., & King, J. C. (2021) · Nutrients · doi:10.3390/nu13030748 · Cited by 13
Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis
Ristić, G. G., Subota, V., Stanisavljevic, D. M., Vojvodić, D., Ristić, A. D., Glišić, B., Petronijević, M., & Stefanović, D. Z. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02476-0 · Cited by 16
Yang, X., Lin, Y., Xu, G., Chen, Y., Zhou, Y., Sun, J., & Li, L. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s304164 · Cited by 13
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
Xie, X., Bai, G., Liu, H., Zhang, L., He, Y., Qiang, D., & Zou, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s301352 · Cited by 13
Maternal Adiposity and Energy Balance After Normotensive and Preeclamptic Pregnancies
McLennan, S., Henry, A., Roberts, L. M., Siritharan, S., Ojurovic, M., Yao, A., Davis, G. K., Mangos, G., Pettit, F. M., Brown, M. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab223 · Cited by 15
Zupo, R., Castellana, F., Panza, F., Castellana, M., Lampignano, L., Cincione, R. I., Triggiani, V., Giannelli, G., Dibello, V., Sardone, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081695 · Cited by 13
Espinoza, C., Fuenzalida, B., & Leiva, A. (2021) · Current Vascular Pharmacology · doi:10.2174/1570161119666210423085407 · Cited by 13
Galarregui, C., Navas‐Carretero, S., González-Navarro, C. J., Martínez, J. A., Zulet, M. Á., & Abete, I. (2021) · Food & Function · doi:10.1039/d1fo00731a · Cited by 13
Villarreal-Calderón, J. R., Castillo, E. C., Cuellar-Támez, R. X., García-Garza, M. R., Elizondo‐Montemayor, L., & García‐Rivas, G. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01587-4 · Cited by 13
Sen, S. B., Kızılay, D. Ö., Taneli, F., Özen, Ç., Ertan, P., Özünan, İ., Yıldız, R., & Ersoy, B. (2021) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2021.2021.0020 · Cited by 13
Frandsen, J., Hansen, I. M. D., Wismann, J., Olsen, M. H., Brage-Andersen, M. R., Sahl, R. E., Hansen, M., Ingersen, A., Modvig, J. L., Schmücker, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab473 · Cited by 13
Aliabadi, M., Zamani‐Garmsiri, F., Panahi, G., Tehrani, S. S., & Meshkani, R. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155638 · Cited by 14
Surbhi, Wittmann, G., Low, M. J., & Lechan, R. M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101312 · Cited by 13
Billmann, F. G., Shishtawi, S. E., Bruckner, T., ElSheikh, M., Müller-Stich, B. P., & Billeter, A. T. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-71 · Cited by 12
Raźny, U., Góralska, J., Calder, P. C., Gruca, A., Childs, C. E., Kapusta, M., Słowińska-Solnica, K., Dembinska-Kiec, A., Solnica, B., & Malczewska-Malec, M. (2021) · Nutrients · doi:10.3390/nu13093096 · Cited by 13
Hillman, A. R., & Chrismas, B. C. R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.733057 · Cited by 13
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial
Tsaban, G., Meir, A. Y., Rinott, E., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.12.11 · Cited by 13
Allam, M. M., Ibrahim, R. M., Gazzar, W. B. E., & Said, M. A. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1975758 · Cited by 13
Glucose/insulin metabolism and vitamin D in women with recurrent pregnancy loss
D’Ippolito, S., Capozzi, A., Scambia, G., Sorge, R. P., Lello, S., & Simone, N. D. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13505 · Cited by 13
de la Rosa, I. A., Escudero‐Contreras, A., Ruiz-Ponce, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744022 · Cited by 13
Krishna, M., Krishnaveni, G. V., Sargur, V., Kumaran, K., Kumar, M. S. P., Nagaraj, K., Coakley, P., Karat, S. C., Chandak, G. R., Varghese, M., et al. (2021) · International Psychogeriatrics · doi:10.1017/s1041610221001186 · Cited by 14
Beunen, K., Astrid, N., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01812-9 · Cited by 13
Leite, N., Tadiotto, M. C., Corazza, P. R. P., de Menezes-Junior, F. J., Carli, M. E. C., Milano, G. E., Lopes, W. A., Gaya, A. R., Brand, C., Mota, J. A. P. S., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01699-x · Cited by 13
Obydah, W., Shaker, G. A., Samir, S. M., El-Basiony, S. F., & Abd-Elmoniem, H. A. (2021) · Physiology International · doi:10.1556/2060.2021.00188 · Cited by 13
Bonilla-Gómez, J. L., López-Rocha, J. A., Badillo‐Alemán, M., Tzeek-Tuz, J., & Chiappa‐Carrara, X. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 13
Roškarić, P., Šperanda, M., Mašek, T., Verbanac, D., & Starčević, K. (2021) · Antioxidants · doi:10.3390/antiox10122005 · Cited by 15
Ali, M. M., Mirza, I., Naquiallah, D., Hassan, C., Masrur, M. A., Bianco, F. M., & Mahmoud, A. M. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010007 · Cited by 13
Pokorska‐Niewiada, K., Brodowska, A., Brodowski, J., & Szczuko, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020976 · Cited by 13
Ren, J., Wang, X., Yee, C., et al. (2022) · Molecules · doi:10.3390/molecules27030727 · Cited by 13
Sanctis, V. D., Soliman, A. T., Tzoulis, P., Daar, S., Karimi, M., Yassin, M. A., Pozzobon, G. C., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92i6.12366 · Cited by 18
Jin, Y.-J., Jang, M. G., Kim, J.-W., Baek, S., Ko, H., Hur, S., & Kim, S. (2022) · Nutrients · doi:10.3390/nu14040865 · Cited by 13
Amador-Lara, F., Andrade-Villanueva, J. F., Vega‐Magaña, N., Rodríguez, M. P., Álvarez-Zavala, M., Sánchez-Reyes, K., Toscano-Piña, M., Peregrina-Lucano, A. A., del Toro‐Arreola, S., González-Hernández, L. A., et al. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15505 · Cited by 13
Ramesh, G., Wood, A. C., Allison, M., Rich, S. S., Jensen, E. T., Chen, Y. I., Rotter, J. I., Bertoni, A. G., & Goodarzi, M. O. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.03.014 · Cited by 14
Pardo, Z., Seiquer, I., Lachica, M., Nieto, R., Lara, L., & Fernández-Fígares, I. (2022) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2022.103230 · Cited by 13
Kufe, C. N., Micklesfield, L. K., Masemola, M., Chikowore, T., Kengne, A. P., Karpe, F., Norris, S. A., Crowther, N. J., Olsson, T., & Goedecke, J. H. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0527 · Cited by 14
Seyres, D., Cabassi, A., Lambourne, J. J., Burden, F., Farrow, S., McKinney, H., Batista, J., Kempster, C., Pietzner, M., Slingsby, O. C., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01257-z · Cited by 13
Korkiakoski, A., Käräjämäki, A. J., Ronkainen, J., AUVINEN, J. P., Hannuksela, J., Kesäniemi, Y. A., & Ukkola, O. H. (2022) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2022.2059698 · Cited by 13
Banu, H., Morshed, M. S., Sultana, T., et al. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_114_21 · Cited by 13
Donbaloğlu, Z., Tuhan, H., Çoban, Ö. G., Kızılay, D. Ö., İsmailoğlu, E., Önder, A., Acar, S., Bedel, A., Çetiner, E. B., Singin, B., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0010 · Cited by 17
Quan, W., Lin, Y., Xue, C., Cheng, Y., Luo, J., Lou, A., Zeng, M., He, Z., Shen, Q. W., & Chen, J. (2022) · Food & Function · doi:10.1039/d2fo00143h · Cited by 13
Ishikawa, Y., Laing, E. M., Anderson, A. K., Zhang, D. “., Kindler, J. M., Trivedi, R., & Sattler, E. L. P. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.04.018 · Cited by 13
Multi-Task Disentangled Autoencoder for Time-Series Data in Glucose Dynamics
Lim, M. H., Cho, Y. M., & Kim, S. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3175928 · Cited by 14
Yang, L., Yang, C., Chu, C., Wan, M., Xu, D., Pan, D., Xia, H., Wang, S. K., Shu, G., Chen, S., et al. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12083 · Cited by 13
Zhang, L., Zhang, M., Wang, M., Wang, M., Zhang, R., Wang, H., Zhang, W., Ding, Y., & Wang, J. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002399 · Cited by 13
Lambert, D. C., Kane, J., Slaton, A., & Abramowitz, M. K. (2022) · Kidney360 · doi:10.34067/kid.0002402022 · Cited by 13
Singh, P. K., Naithani, M., Pathania, M., Mirza, A. A., & Saha, S. (2022) · Cureus · doi:10.7759/cureus.27123 · Cited by 13
Insulin resistance and related factors in patients with moderate and severe traumatic brain injury
Korkmaz, N., Kesikburun, S., Atar, M. Ö., et al. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03147-y · Cited by 13
Wang, X., Sun, X., Abulizi, A., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00868-z · Cited by 13
Etzel, T., Kuiper, J. R., Wang, X., et al. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114102 · Cited by 13
Wernicke, C., Pohrt, A., Pletsch‐Borba, L., Apostolopoulou, K., Hornemann, S., Meyer, N. M. T., Machann, J., Gerbracht, C., Tacke, F., Pfeiffer, A. F. H., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.01.010 · Cited by 17
Are Women with Normal-Weight Obesity at Higher Risk for Cardiometabolic Disorders?
Ashtary‐Larky, D., Niknam, S., Alipour, M., Bagheri, R., Asbaghi, O., Mohammadian, M., Jaime, S. J., Baker, J. S., Wong, A., Suzuki, K., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020341 · Cited by 13
Yamazaki, H., Uehara, M., Yoshikawa, N., Souta-Kuribara, A., Yamamoto, M., Hirakawa, Y., Kabe, Y., Suematsu, M., & Tanaka, H. (2023) · JCI Insight · doi:10.1172/jci.insight.162382 · Cited by 14
Berezin, A. A., Obradovic, A. B., Fushtey, I. M., Berezina, T. A., Lichtenauer, M., & Berezin, A. E. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10040136 · Cited by 13
Sosenko, J. M., Cuthbertson, D. D., Sims, E. K., Ismail, H. M., Nathan, B. M., Jacobsen, L. M., Atkinson, M. A., Evans‐Molina, C., Herold, K. C., Skyler, J. S., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2236 · Cited by 13
Shashikadze, B., Valla, L., Lombardo, S. D., Prehn, C. P., Haid, M., Riols, F., Stöckl, J. B., Elkhateib, R., Renner, S., Rathkolb, B., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101768 · Cited by 13
da Costa, M. S., Pontes, K. S. D. S., Guedes, M. R., Silva, M. I. B., & Klein, M. R. S. T. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.004 · Cited by 14
Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study
Atzeni, A., Nishi, S. K., Babió, N., Belzer, C., Konstanti, P., Vioqué, J., Corella, D., Castañer, O., Vidal, J., Moreno‐Indias, I., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246185 · Cited by 14
Özdemir, D., Dağdelen, S., & Usman, A. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.0668 · Cited by 13
Oh, T. J., Lee, H., & Cho, Y. M. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1879-0 · Cited by 14
Association between insulin resistance and metabolic syndrome risk factors in Japanese
Yamada, C., Moriyama, K., & Takahashi, E. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00162.x · Cited by 13
Imad (2012) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2012.157.163 · Cited by 13
Meas, T., Deghmoun, S., Chevenne, D., Gaborit, B., Alessi, M., & Lévy‐Marchal, C. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04037.x · Cited by 13
Μanios, Y., Moschonis, G., Papandreou, C., Siatitsa, P.-E., Iatridi, V., Lidoriki, I., Lionis, C. D., & G, G. P. C. O. B. O. T. H. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12052 · Cited by 13
Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community
Bari, M. R., Östgren, C. J., Råstam, L., & Lindblad, U. (2006) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430601035290 · Cited by 13
Menezes, C. N., Duarte, R., Dickens, C., et al. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.01054.x · Cited by 13
Cardio-metabolic risk factors in Argentine children. A comparative study
Sobrero, Á. F., Evangelista, P. G., Kovalskys, I., Digón, P., López, S. M., Scaiola, E., Perez, N., Dieuzeide, G., Walz, F., & Mazza, C. S. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.10.003 · Cited by 13
Fasting gut hormone levels change with modest weight loss in obese adolescents
Jensen, D. E., Nguo, K., Baxter, K. A., Cardinal, J. W., King, N. A., Ware, R. S., Truby, H., & Batch, J. (2015) · Pediatric Obesity · doi:10.1111/ijpo.275 · Cited by 16
Effects of a Macro-Nutrient Preload on Type 2 Diabetic Patients
Li, C., Norstedt, G., Hu, Z., Yu, P., Li, D., Li, J., Yu, Q., Sederholm, M., & Yu, D. M. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00139 · Cited by 13
Assessment of the Adherence of Cardiologists to Guidelines for the Treatment of Atrial Fibrillation
van der Sand, C. R., Leiria, T. L. L., & Kalil, R. A. K. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130148 · Cited by 13
de Luis, D. A., Aller, R., Izaola, O., Díaz-Soto, G., Gómez, J. J. L., Hoyos, E. G., Torres, B., Villar, A., & Romero, E. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000375412 · Cited by 13
Kim, H., Kim, C., Kim, E., Bae, S., & Park, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.012 · Cited by 12
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
